FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3176702940> ?p ?o ?g. }

• W3176702940 endingPage "101282" @default.
• W3176702940 startingPage "101282" @default.
• W3176702940 abstract "Dual amylin and calcitonin receptor agonists (DACRAs) are novel therapeutic agents that not only improve insulin sensitivity but also work as an adjunct to established T2DM therapies. DACRAs are currently administered once daily, though it is unknown whether DACRAs with increased plasma half-life can be developed as a once-weekly therapy. The in vitro potencies of the KBP-066A and KBP-066 (non-acylated) were assessed using reporter assays. Acylation functionality was investigated by a combination of pharmacokinetics and acute food intake in rats. in vivo efficacies were investigated head-to-head in obese (HFD) and T2D (ZDF) models. In in vitro, KBP-066A activated the CTR and AMY-R potently, with no off-target activity. Acylation functionality was confirmed by acute tests, as KBP-066A demonstrated a prolonged PK and PD response compared to KBP-066. Both compounds induced potent and dose-dependent weight loss in the HFD rat model. In ZDF rats, fasting blood glucose/fasting insulin levels (tAUC) were reduced by 39%/50% and 36%/47% for KBP-066 and KBP-066A, respectively. This effect resulted in a 31% and 46% vehicle-corrected reduction in HbA1c at the end of the study for KBP-066 and KBP-066A, respectively. Here, we present pre-clinical data on an acylated DACRA, KBP-066A. The in vivo efficacy of KBP-066A is significantly improved compared to its non-acylated variant regarding weight loss and glycemic control in obese (HFD) and obese diabetic rats (ZDF). This compendium of pre-clinical studies highlights KBP-066A as a promising, once-weekly therapeutic agent for treating T2DM and obesity." @default.
• W3176702940 created "2021-07-05" @default.
• W3176702940 creator A5036270002 @default.
• W3176702940 creator A5049421061 @default.
• W3176702940 creator A5062465642 @default.
• W3176702940 creator A5066080561 @default.
• W3176702940 creator A5077488254 @default.
• W3176702940 creator A5082542112 @default.
• W3176702940 date "2021-11-01" @default.
• W3176702940 modified "2023-10-01" @default.
• W3176702940 title "KBP-066A, a long-acting dual amylin and calcitonin receptor agonist, induces weight loss and improves glycemic control in obese and diabetic rats" @default.
• W3176702940 cites W1533485972 @default.
• W3176702940 cites W1888846292 @default.
• W3176702940 cites W1986267285 @default.
• W3176702940 cites W2010033044 @default.
• W3176702940 cites W2043900831 @default.
• W3176702940 cites W2054981500 @default.
• W3176702940 cites W2088989468 @default.
• W3176702940 cites W2110979442 @default.
• W3176702940 cites W2117764934 @default.
• W3176702940 cites W2138077952 @default.
• W3176702940 cites W2152887514 @default.
• W3176702940 cites W2162140339 @default.
• W3176702940 cites W2235318197 @default.
• W3176702940 cites W2258379738 @default.
• W3176702940 cites W2395142674 @default.
• W3176702940 cites W2429044373 @default.
• W3176702940 cites W2482034241 @default.
• W3176702940 cites W2578922157 @default.
• W3176702940 cites W2595209157 @default.
• W3176702940 cites W2596005234 @default.
• W3176702940 cites W2597042371 @default.
• W3176702940 cites W2609525834 @default.
• W3176702940 cites W2895135221 @default.
• W3176702940 cites W2941916221 @default.
• W3176702940 cites W2948622224 @default.
• W3176702940 cites W2953065467 @default.
• W3176702940 cites W3003895264 @default.
• W3176702940 cites W3007883741 @default.
• W3176702940 cites W3017130668 @default.
• W3176702940 cites W3030007836 @default.
• W3176702940 cites W433553030 @default.
• W3176702940 cites W2238427180 @default.
• W3176702940 doi "https://doi.org/10.1016/j.molmet.2021.101282" @default.
• W3176702940 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8313742" @default.
• W3176702940 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34214708" @default.
• W3176702940 hasPublicationYear "2021" @default.
• W3176702940 type Work @default.
• W3176702940 sameAs 3176702940 @default.
• W3176702940 citedByCount "13" @default.
• W3176702940 countsByYear W31767029402022 @default.
• W3176702940 countsByYear W31767029402023 @default.
• W3176702940 crossrefType "journal-article" @default.
• W3176702940 hasAuthorship W3176702940A5036270002 @default.
• W3176702940 hasAuthorship W3176702940A5049421061 @default.
• W3176702940 hasAuthorship W3176702940A5062465642 @default.
• W3176702940 hasAuthorship W3176702940A5066080561 @default.
• W3176702940 hasAuthorship W3176702940A5077488254 @default.
• W3176702940 hasAuthorship W3176702940A5082542112 @default.
• W3176702940 hasBestOaLocation W31767029401 @default.
• W3176702940 hasConcept C112705442 @default.
• W3176702940 hasConcept C118303440 @default.
• W3176702940 hasConcept C126322002 @default.
• W3176702940 hasConcept C134018914 @default.
• W3176702940 hasConcept C150903083 @default.
• W3176702940 hasConcept C163170386 @default.
• W3176702940 hasConcept C165220095 @default.
• W3176702940 hasConcept C170493617 @default.
• W3176702940 hasConcept C207001950 @default.
• W3176702940 hasConcept C2777180221 @default.
• W3176702940 hasConcept C2778938600 @default.
• W3176702940 hasConcept C2779306644 @default.
• W3176702940 hasConcept C2780473172 @default.
• W3176702940 hasConcept C2780705028 @default.
• W3176702940 hasConcept C511355011 @default.
• W3176702940 hasConcept C544821477 @default.
• W3176702940 hasConcept C555293320 @default.
• W3176702940 hasConcept C71924100 @default.
• W3176702940 hasConcept C86803240 @default.
• W3176702940 hasConcept C92316933 @default.
• W3176702940 hasConcept C98274493 @default.
• W3176702940 hasConceptScore W3176702940C112705442 @default.
• W3176702940 hasConceptScore W3176702940C118303440 @default.
• W3176702940 hasConceptScore W3176702940C126322002 @default.
• W3176702940 hasConceptScore W3176702940C134018914 @default.
• W3176702940 hasConceptScore W3176702940C150903083 @default.
• W3176702940 hasConceptScore W3176702940C163170386 @default.
• W3176702940 hasConceptScore W3176702940C165220095 @default.
• W3176702940 hasConceptScore W3176702940C170493617 @default.
• W3176702940 hasConceptScore W3176702940C207001950 @default.
• W3176702940 hasConceptScore W3176702940C2777180221 @default.
• W3176702940 hasConceptScore W3176702940C2778938600 @default.
• W3176702940 hasConceptScore W3176702940C2779306644 @default.
• W3176702940 hasConceptScore W3176702940C2780473172 @default.
• W3176702940 hasConceptScore W3176702940C2780705028 @default.
• W3176702940 hasConceptScore W3176702940C511355011 @default.
• W3176702940 hasConceptScore W3176702940C544821477 @default.
• W3176702940 hasConceptScore W3176702940C555293320 @default.

• next